We provide first-rate strategic intelligence in nuclear medicine, radiopharmaceutical, cyclotron, proton therapy and brachytherapy.
MEDraysintell publishes the 9th. Edition of its Nuclear Medicine Report & Directory
A set of three volumes (3,500 pages) with a description of 970 products, together with a comprehensive profile of 380 companies active around the world in the radiopharmaceutical industry.
MEDraysintell publishes the 8th. Edition of its Nuclear Medicine Report & Directory
A set of three volumes (3,100 pages) with a description of 870 products, together with a comprehensive profile of 340 companies active around the world in the radiopharmaceutical industry.
Proton therapy market headwinds: demand down, supply up, but increasing awareness
The new Proton Therapy World Market Report & Directory, Edition 2021 is a 380-page document featuring a comprehensive review of the world market dynamics.
MEDraysintell to showcase its Reports during the EANM virtual congress
This unique work was recently updated and describes in over 4,000 pages the state-of-the-art in Nuclear Medicine, Cyclotrons, Brachytherapy and Proton Therapy.
MEDraysintell welcomes Jean-Luc Vanderheyden as Advisor
Jean-Luc Vanderheyden joins MEDraysintell as Advisor and brings his extended experience (35 years) in the field of nuclear medicine.
MEDraysintell releases its new and unique report “Cyclotrons used in Nuclear Medicine Report & Directory, Edition 2020” that describes close to 1,500 medical cyclotrons worldwide
A 450-page report which provides an extensive review of all cyclotrons installed worldwide.